about
PD-L1 expression induced by the 2009 pandemic influenza A(H1N1) virus impairs the human T cell responseQuantifying the mortality caused by the H1N1 influenza virus during the 2009 pandemic in Mexico.Pregnant women infected with pandemic H1N1pdm2009 influenza virus displayed overproduction of peripheral blood CD69+ lymphocytes and increased levels of serum cytokines.Antibody responses to influenza viruses in paediatric patients and their contacts at the onset of the 2009 pandemic in Mexico.Differential Immune Profiles in Two Pandemic Influenza A(H1N1)pdm09 Virus Waves at Pandemic Epicenter.Salmonella Typhi Porins OmpC and OmpF Are Potent Adjuvants for T-Dependent and T-Independent Antigens.Salmonella Typhi OmpS1 and OmpS2 porins are potent protective immunogens with adjuvant properties.Evolution of Salmonella Typhi outer membrane protein-specific T and B cell responses in humans following oral Ty21a vaccination: A randomized clinical trialB1b cells recognize protective antigens after natural infection and vaccination.Natural and vaccine-mediated immunity to Salmonella Typhimurium is impaired by the helminth Nippostrongylus brasiliensis.A novel M2e based flu vaccine formulation for dogs.CD31 is required on CD4+ T cells to promote T cell survival during Salmonella infectionEditorial: How Salmonella Infection can Inform on Mechanisms of Immune Function and Homeostasis.LLT1 and CD161 Expression in Human Germinal Centers Promotes B Cell Activation and CXCR4 Downregulation.Dysregulated humoral immunity to nontyphoidal Salmonella in HIV-infected African adultsThe porin OmpD from nontyphoidal Salmonella is a key target for a protective B1b cell antibody responseTranslating innate response into long-lasting antibody response by the intrinsic antigen-adjuvant properties of papaya mosaic virus.Control and Resolution Mechanisms of the Inflammatory Response 2016.Activated endothelial cells limit inflammatory response, but increase chemoattractant potential and bacterial clearance by human monocytes.Control and resolution mechanisms of the inflammatory response.Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: evidence for the critical function of multimerization.Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform.Effect of Oral ω3-Polyunsaturated Fatty Acids as a Complement Management to Control Fistula Output and Inflammation in Patients With Digestive Fistula.Subversion of innate and adaptive immune activation induced by structurally modified lipopolysaccharide from Salmonella typhimurium.Soluble flagellin, FliC, induces an Ag-specific Th2 response, yet promotes T-bet-regulated Th1 clearance of Salmonella typhimurium infection.TLR2 and TLR4 signaling shapes specific antibody responses to Salmonella typhi antigens.Induction of antibodies against Salmonella typhi OmpC porin by naked DNA immunization.Impaired selective cytokine production by CD4(+) T cells in Common Variable Immunodeficiency associated with the absence of memory B cells.Mycobacterium tuberculosis lipids regulate cytokines, TLR-2/4 and MHC class II expression in human macrophagesLipopopeptidephosphoglycan from Entamoeba histolytica activates human macrophages and dendritic cells and reaches their late endosomesAntiviral protection after DNA vaccination is short lived and not enhanced by CpG DNALipophosphopeptidoglycan of Entamoeba histolytica Induces an Antiinflammatory Innate Immune Response and Downregulation of Toll-Like Receptor 2 (TLR-2) Gene Expression in Human Monocytes
P50
Q24339361-F70D97E8-2F00-444F-943A-F09EAFCD60C0Q30363474-DF322114-DD20-4DC3-BB94-B7296F3DA759Q30367153-7F58649E-FC9E-438D-8B6D-FC6A65CB2477Q30372687-016107A9-F8B2-4A4D-BF1B-86FB31D1BEB3Q30382796-136E8BAB-A686-4BA8-971F-531676CB2A9CQ30400261-1BB20E22-5CB2-4EC8-B147-02EA1812C4D8Q30427484-9EEC8AE1-A959-42D3-AE6C-370648339043Q33751908-CDEF0F57-7AA4-426D-A015-26AE85E762DCQ34433081-434ADAAA-4200-4614-AF35-62291C44D99AQ34633967-020E46B7-9E78-4031-95CA-F1C41405457DQ35009732-BE37DB2F-10D7-4E0A-A2D7-DA93E088FA44Q35177794-718BA15F-6345-48DE-9A27-84CBE55B3D02Q36022382-13D981B9-50D1-4223-B679-A9F528D23FB4Q36597292-2A4CF19D-C41C-41A5-9846-9EE6B8CA0710Q37168665-16AC8E93-F23D-46C1-8072-1CC150312733Q37239010-319C46F1-237D-425B-9B9C-73948C6D9BD3Q40432402-6BC79656-2882-4399-B5E4-D243F0BB29FBQ41319772-4BB21FA9-CCE3-4C46-9FBF-F48B44E4E493Q41566183-EB7C8006-B619-4F0F-8783-EBB3F605361DQ42668661-657177E4-62F4-42AA-888C-AB819DB3AD63Q43036230-21554A4D-3A96-4AB1-AA94-CD8F72601A00Q45394726-1DFB647B-4625-45C7-B042-9962773FC055Q48183994-DD8EAA51-B705-43B8-8884-1402416B0783Q50041674-CB466AA4-4617-4B15-BA7E-F1C8E5DE0A57Q50042606-9F2B3AC8-CCF2-4604-828E-6F21D4DB0E5EQ50057324-5ECEB88D-9C4A-43C6-A716-21F09FD7D32EQ50141631-258F3710-98CC-4C96-B9DE-9A72B9F0371AQ50219967-856024D0-BBD1-4ED4-9B4E-27A85AEC6215Q58608724-E666A7D1-19A7-4DD8-81C4-A5D38A53EFF4Q58608734-8D3E4A00-C34E-4CF5-B038-34D02ABEFE56Q58608760-15EB585A-8DDB-43CF-AF0A-6DB633CE00CEQ58608765-022EEAA9-1F8C-42F8-90CE-A5E8B773CD84
P50
description
researcher
@en
name
C López-Macías
@en
C López-Macías
@nl
type
label
C López-Macías
@en
C López-Macías
@nl
prefLabel
C López-Macías
@en
C López-Macías
@nl
P106
P31
P496
0000-0002-7756-8468